ROKIT Healthcare Inc. (KOSDAQ:376900)
18,020
-4,380 (-19.55%)
At close: Oct 22, 2026
ROKIT Healthcare Revenue
ROKIT Healthcare had revenue of 8.22B KRW in the quarter ending June 30, 2026, with 36.64% growth. This brings the company's total for the last twelve months to 32.81B, up 106.19% year-over-year. In the year 2025, ROKIT Healthcare had annual revenue of 26.25B with 100.19% growth. That makes ROKIT Healthcare the 32,575th largest company in the world by revenue and 2,074th in South Korea.
Revenue (ttm)
32.81B
Revenue Growth
+106.19%
P/S Ratio
9.54
Revenue / Employee
360.59M
Employees
91
Market Cap
312.90B
Revenue by Geography
- South Korea 14.68B 55.9%
- Overseas 11.57B 44.1%
Fiscal year ended Dec 31, 2025 See the full ROKIT Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.25B | 13.14B | 100.19% |
| Dec 31, 2024 | 13.11B | 693.67M | 5.59% |
| Dec 31, 2023 | 12.42B | 3.27B | 35.70% |
| Dec 31, 2022 | 9.15B | 2.41B | 35.76% |
| Dec 31, 2021 | 6.74B | 2.75B | 68.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 124.81B |
| Genome & Company | 24.46B |
| JS Link | 22.78B |
| S.Biomedics | 16.49B |
| curacle co.,ltd. | 8.24B |
| IntoCell | 3.19B |
| Inventage Lab | 2.47B |
| AprilBio | 725.35M |